As healthcare professionals, one of the common complaints we encounter is dizziness, a symptom that can be indicative of various underlying conditions. The most prevalent of these is vertigo, a sensation of movement or spinning when one is stationary. This article aims to provide a comprehensive clinical approach to vertigo, helping you identify and manage this condition effectively.
Vertigo is often a symptom of vestibular disorders and is characterized by a sensation of spinning or feeling off-balance. It is primarily attributed to issues in the inner ear or brain. Distinguishing vertigo from other types of dizziness is crucial, as it helps narrow down potential causes and dictates the course of treatment.
Diagnosing vertigo involves a thorough patient history, physical examination, and targeted investigations. Key elements of the history include onset, duration, triggers, and associated symptoms. Physical examination often focuses on nystagmus, head impulse testing, and Romberg's sign. Investigations like electronystagmography (ENG), videonystagmography (VNG), and magnetic resonance imaging (MRI) can be useful in complex cases.
Management of vertigo primarily involves treating the underlying cause. Vestibular suppressants, such as meclizine and diazepam, can provide symptomatic relief but are not recommended for long-term use. Vestibular rehabilitation therapy (VRT), a form of physical therapy, is often beneficial in chronic cases. In some instances, surgical intervention may be necessary.
Vertigo presents a unique challenge due to its varied causes and nonspecific symptomatology. A comprehensive clinical approach, involving careful history taking, physical examination, and appropriate investigations, is crucial to accurately diagnose and manage this condition. As healthcare professionals, it is our responsibility to stay updated on the latest diagnostic techniques and treatment modalities to provide the best care possible for our patients.
1.
Research discovery halts childhood brain tumor before it forms
2.
Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.
3.
'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning
4.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
5.
Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers
1.
Beyond the Blinders: A Review of Targeted Therapeutic Strategies for Triple-Negative Breast Cancer in 2025
2.
AI-Based Cancer Follow-Up Monitoring: Transforming Survivorship Care through Intelligent Surveillance
3.
Preventing Sarcopenia During Cancer Treatment
4.
Guidance for Managing Complex Anticoagulation
5.
Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on Standard V/S High Risk Myeloma Treatment
2.
Navigating the Complexities of Ph Negative ALL - Part XIV
3.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation